Ewan R Pearson
University of Dundee · University of Dundee / NHS Tayside · NHS Tayside
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ewan R Pearson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:55 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03705195 · Study of Sulphonylurea Synergy With IncretinsUniversity of Dundee · completed · Type 2 Diabetes Mellitus · study chair
- Ph4NCT02586636 · Impact of OCT1 on Metformin ToleranceNHS Tayside · completed · Tolerance · study chair
- Ph4NCT00780715 · Response To Oral Agents in Diabetes (ROAD)- Pilot StudyUniversity of Dundee · completed · Diabetes Mellitus, Type 2 · principal investigator
- Ph4NCT00738088 · Variation in Sulphonylurea Response in Type 2 DiabetesNHS Tayside · terminated · Diabetes Mellitus, Type 2 · principal investigator
- N/ANCT00334711 · Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 MutationsRoyal Devon and Exeter NHS Foundation Trust · completed · Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:55 UTC. The ranking covers the 200 most relevant of 18 PubMed records, and a shared surname and initials can bring in a namesake. All 18 on PubMed
- 424 citationsRCR 7.9
- Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial.Diabetes Care · 2020136 citationsRCR 6.7
- No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas.Diabetes Care · 200393 citationsRCR 1.7
- The CTRB1/2 locus affects diabetes susceptibility and treatment via the incretin pathway.Diabetes · 201380 citationsRCR 2.3
- Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study.Nat Med · 202356 citationsRCR 4.6
- Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design.Cardiovasc Diabetol · 201647 citationsRCR 1.6
- Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.Diabetes Obes Metab · 201747 citationsRCR 1.8
- Pharmacokinetics of metformin in patients with gastrointestinal intolerance.Diabetes Obes Metab · 201846 citationsRCR 1.9
- Genetic Variants in CPA6 and PRPF31 Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes.Diabetes · 201845 citationsRCR 1.7
- 44 citationsRCR 0.9